The pathogenesis and treatment of Evans syndrome
3.2 هزار بار بازدید -
2 سال پیش
-
V. Koneti Rao, MD, FRCPA,
V. Koneti Rao, MD, FRCPA, National Institute of Allergy and Infectious Diseases, Bethesda, MD talks on the pathogenesis and treatment of Evans syndrome (ES), defined as an autoimmune condition that presents with two or more cytopenias - commonly autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Dr Rao emphasizes the importance of conducting a genetic evaluation of patients diagnosed with Evans syndrome to allow for specific, targeted treatment. Dr Rao also explains that in the future, striving toward more genetically or epigenetically targeted treatments is key in the management of chronic disease. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
2 سال پیش
در تاریخ 1401/04/31 منتشر شده
است.
3,246
بـار بازدید شده